This model offers unique
capabilities for preclinical assessment of thrombosis risk in a patient - specific manner, including efficacy testing of anti-thrombotic agents,
elucidation of mechanism of action, and, potentially, biomarker identification, all providing a much - needed platform for drug discovery and development.